医药日报｜复星医药希望在未来打造50亿美元级重磅产品 先瑞达医疗上半年营收大增106.0% _ 东方财富网

医药日报：①复星医药希望在未来打造50亿美元级重磅产品；②先瑞达医疗上半年营收大增106.0%；③泰格医药上半年净利升25.65%；④环亚国际医疗集团预期中期亏损大幅减少54%；⑤甘陕联盟集采报价解密，25家企业28个药品进入二次议价；⑥探索生物医药产业的“上海方案”：上实集团、上海医药等发起设立创新转化基金。

Related Keywords

Shanghai ,China ,United States ,Thailand ,Switzerland ,Shaanxi ,Gansu ,Zhou Jun ,Guangdong ,Shanxi Jinzhong Zhejiang ,Novo Nordisk ,Jiaxing Haiyan Anhui ,Technology Shanghai ,Funda Shanghai ,Branch The Fund ,Jun Union ,Express ,Management Service ,China Times ,Fund Shanghai ,Gan Shaanxi Union ,Researchi Center ,Center Web ,Group Shanghai ,Country Health ,Fund Philip ,Daily Star ,Fund August ,Country Square ,Shanghai Angels ,Country Guardian ,Commission General Office ,Ili Kazakhstan Autonomous ,August Country ,May Gansu Province Public ,Chung Science ,Technology Limited ,Medical Service ,Fine Operations ,China Market ,Kang Switzerland ,Medical Group ,Southeast Asia ,Pan Asia Country ,East Sun ,August East Sun ,医药 ,日报 ,复星医药 ,产品 ,先瑞达医疗 ,上半年营收 ,重磅 ,基金 ,上实集团 ,生物医药 ,